AXGN – axogen, inc. (US:NASDAQ)
Stock Stats
News
AxoGen (NASDAQ:AXGN) was given a new $37.00 price target on by analysts at Canaccord Genuity Group Inc..
AxoGen (NASDAQ:AXGN) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
AxoGen (NASDAQ:AXGN) had its "buy" rating reaffirmed by analysts at Lake Street Capital.
AxoGen (NASDAQ:AXGN) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx) [Yahoo! Finance]
Form 8-K Axogen, Inc. For: Dec 03
Form SCHEDULE 13G/A Axogen, Inc. Filed by: First Light Asset Management, LLC
Form 144 Axogen, Inc. Filed by: Burke William P. Mr.
Form 144 Axogen, Inc. Filed by: Burke William P. Mr.
Form 4 Axogen, Inc. For: Nov 05 Filed by: Burke William P. Mr.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.